The CSIR has established a bioconversion platform that focuses on alternative pathways for chemical production. The platform is geared towards local production and replacing imports of bio-based platform chemicals, including lactic acid. This shift will have a direct impact on the bioeconomy. The
The recombinant LSDV-BCoV vaccine is an innovative dual vaccine designed to provide simultaneous protection against Lumpy Skin Disease Virus (LSDV) and Bovine Coronavirus (BCoV). It utilises a recombinant LSDV vector to express key BCoV antigens, including the spike (S1 and S2 subunits) and